Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana

• Status: Unknown status
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if Artemisinin-based Combination Therapy, ACT,(artemether-lumefantrine) used as intermittent preventive treatment (IPT) alone or in combination with praziquantel, will have any effects on anemia, malaria, schistosomiasis and school sustained attention and concentration.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Navrongo Health Research Centre, Ghana
• Collaborator: DBL -Institute for Health Research and Development
• Treatments: Albendazole; Artemether; Artemether-lumefantrine combination; Artemether, Lumefantrine Drug Combination; Artemisinine; Artemisinins; Lumefantrine; Praziquantel

Criteria

Inclusion Criteria:

• Parental informed consent and assent by schoolchildren

• No known history of allergy to any study drug

• Aged 6 or more years

Exclusion Criteria:

• lack of parental informed consent and assent by schoolchildren

• Known allergy or history of allergy to any study drug

• Aged less than 6 years